featured
Apixaban vs Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease: A Population-Based Study
Ann. Intern. Med 2022 Oct 18;[EPub Ahead of Print], GK Dawwas, A Cuker, GD Barnes, JD Lewis, S HennessyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.